FederalPA
Posted
Sep 1, 2026
Closes
Sep 17, 2026
6505--FDG Radiopharmaceutical
The Department of Veterans Affairs is requesting quotations from a Nuclear Regulatory Commission-licensed vendor to supply Fluorodeoxyglucose (FDG) radiopharmaceuticals for the Philadelphia VA Medical Center. The requirement supports PET/CT imaging and includes unit-dose labeling, radioactive-material packaging, routine and priority delivery, returns or credits for unused doses, and monthly invoicing. The estimated period of performance is October 14, 2026, through October 13, 2031, and quotations are due September 17, 2026, at 6:00 a.m. EDT.
